Anti-ARHGAP22 monoclonal antibody

Pre-made anti-ARHGAP22 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ARHGAP22/ARHGAP22 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2347-Ab-1/ GM-Tg-hg-IP2347-Ab-2Anti-Human ARHGAP22 monoclonal antibodyHuman
GM-Tg-rg-IP2347-Ab-1/ GM-Tg-rg-IP2347-Ab-2Anti-Rat ARHGAP22 monoclonal antibodyRat
GM-Tg-mg-IP2347-Ab-1/ GM-Tg-mg-IP2347-Ab-2Anti-Mouse ARHGAP22 monoclonal antibodyMouse
GM-Tg-cynog-IP2347-Ab-1/ GM-Tg-cynog-IP2347-Ab-2Anti-Cynomolgus/ Rhesus macaque ARHGAP22 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2347-Ab-1/ GM-Tg-felg-IP2347-Ab-2Anti-Feline ARHGAP22 monoclonal antibodyFeline
GM-Tg-cang-IP2347-Ab-1/ GM-Tg-cang-IP2347-Ab-2Anti-Canine ARHGAP22 monoclonal antibodyCanine
GM-Tg-bovg-IP2347-Ab-1/ GM-Tg-bovg-IP2347-Ab-2Anti-Bovine ARHGAP22 monoclonal antibodyBovine
GM-Tg-equg-IP2347-Ab-1/ GM-Tg-equg-IP2347-Ab-2Anti-Equine ARHGAP22 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2347-Ab-1/ GM-Tg-hg-IP2347-Ab-2; GM-Tg-rg-IP2347-Ab-1/ GM-Tg-rg-IP2347-Ab-2;
GM-Tg-mg-IP2347-Ab-1/ GM-Tg-mg-IP2347-Ab-2; GM-Tg-cynog-IP2347-Ab-1/ GM-Tg-cynog-IP2347-Ab-2;
GM-Tg-felg-IP2347-Ab-1/ GM-Tg-felg-IP2347-Ab-2; GM-Tg-cang-IP2347-Ab-1/ GM-Tg-cang-IP2347-Ab-2;
GM-Tg-bovg-IP2347-Ab-1/ GM-Tg-bovg-IP2347-Ab-2; GM-Tg-equg-IP2347-Ab-1/ GM-Tg-equg-IP2347-Ab-2
Products NameAnti-ARHGAP22 monoclonal antibody
Formatmab
Target NameARHGAP22
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-ARHGAP22 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2347-Ag-1Recombinant multi-species RHG22/ ARHGAP22/ RhoGAP2 protein
    ORF Viral VectorvGMLV000693human ARHGAP22 Lentivirus particle
    ORF Viral VectorpGMLV000693human ARHGAP22 Lentivirus plasmid


    Target information

    Target IDGM-IP2347
    Target NameARHGAP22
    Gene ID58504,239027,306279,710956,100685787,101095047,509022,100063193
    Gene Symbol and SynonymsARHGAP22,B230341L19Rik,p68RacGAP,RhoGAP2,RhoGap22
    Uniprot AccessionQ7Z5H3
    Uniprot Entry NameRHG22_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000128805
    Target ClassificationN/A

    The target: ARHGAP22, gene name: ARHGAP22, also named as RhoGAP2, RhoGap22. This gene encodes a member of the GTPase activating protein family which activates a GTPase belonging to the RAS superfamily of small GTP-binding proteins. The encoded protein is insulin-responsive, is dependent on the kinase Akt and requires the Akt-dependent 14-3-3 binding protein which binds sequentially to two serine residues. The result of these interactions is regulation of cell motility. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.